CVR: 36497661
Secondary names: aQuant A/S, MedTrace A/S
Previous names: LSW MEDICAL IVS, Medtrace ApS, MedTrace A/S
DKK 1,759,371
Revenue
Net result: DKK -35,131,112
Arbejdsmarkedets Tillægspension, MedTravest IV ApS
2 more
CVR · view ownership and management
Owner registered: Arbejdsmarkedets Tillægspension
CVR · 14/04/2026
View the full event history
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 8 employees (2018). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.
Source: annual report 2025, Danish Business Authority
The financial health of MedTrace Pharma A/S shows significant challenges, with consistent losses over the past five years. Revenue peaked at 2,645,338 DKK in 2023 but has since declined to 1,759,371 DKK in 2025, while cumulative losses have reached -35,131,112 DKK in the latest year. Despite these losses, the company maintains a strong equity position of 302,613,643 DKK, indicating resilience and potential for recovery. However, the declining revenue trend and persistent negative profit margins raise concerns about its operational sustainability within the event equipment leasing industry.
AI-generated summary · Generated 14/05/2026
Selskabets formål er at udvikle, kommercialisere og sælge et automatisk injektionssystem til radioaktivt vand.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.8 mio. | -35.1 mio. | 337.1 mio. | 302.6 mio. | 31 | |
| 202401/01/2024 – 31/12/2024 | 2.3 mio. | -15.4 mio. | 289.6 mio. | 270.1 mio. | 35 | |
| 202301/01/2023 – 31/12/2023 | 2.6 mio. | -15.1 mio. | 307.6 mio. | 285.2 mio. | 36 | |
| 202201/01/2022 – 31/12/2022 | 2.2 mio. | -37 mio. | 190.7 mio. | 161.2 mio. | 29 | |
| 202101/01/2021 – 31/12/2021 | 1.5 mio. | -17.9 mio. | 119.5 mio. | 93.7 mio. | - | |
| 202001/01/2020 – 31/12/2020 | - | 1.2 mio. | 58.5 mio. | 34.6 mio. | 5 | |
| 201901/01/2019 – 31/12/2019 | - | -1 mio. | 37 mio. | 5.7 mio. | 5 | |
| 201801/01/2018 – 31/12/2018 | - | -1.2 mio. | 25.2 mio. | 6.7 mio. | 5 | |
| 201701/01/2017 – 31/12/2017 | - | -2 mio. | 15.3 mio. | 2.4 mio. | 5 | |
| 201601/01/2016 – 31/12/2016 | - | 1.2 mio. | 10.6 mio. | 4.2 mio. | 4 | |
| 201505/01/2015 – 31/12/2015 | - | -245.5 mio. | 3.1 mia. | 2.8 mia. | - |
Compared to 474 companies in Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringMedTrace Pharma A/S was founded on 5 January 2015.
MedTrace Pharma A/S is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events (industry code 773910).
MedTrace Pharma A/S had 8 employees in 2018 according to the Danish CVR register.
The owners of MedTrace Pharma A/S include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK.
medtrace.dk belongs to MedTrace Pharma A/S, CVR number 36497661.
In 2025, MedTrace Pharma A/S reported revenue of DKK 1,759,371.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 31388581, new email: [email protected], new website: www.medtrace.dk (May 13, 2026).
MedTrace Pharma A/S has published its annual report for 2025. Revenue came to DKK 1,759,371, and the net result was DKK -35,131,112.
As of April 14, 2026, Arbejdsmarkedets Tillægspension is registered as an owner of MedTrace Pharma A/S with an ownership share of 33%.
As of April 14, 2026, MedTravest IV ApS is registered as an owner of MedTrace Pharma A/S with an ownership share of 15%.
Contact info changed: new phone: 31388581, new email: [email protected], new website: www.medtrace.dk (February 9, 2026).
Contact info changed: new phone: 31388581, new email: [email protected], new website: www.medtrace.dk (February 6, 2026).
Contact info changed: new phone: 31388581, new email: [email protected], new website: www.medtrace.dk (January 22, 2026).
Contact info changed: new phone: 31388581, new email: [email protected], new website: www.medtrace.dk (January 15, 2026).
As of January 1, 2026, Ellen Rietmann Ahl has joined the board of directors of MedTrace Pharma A/S.
As of December 31, 2025, Robert Karl Schier has left the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has won the tender "Kontrakt for levering af vandgenerator med infusionssystem til perfusionsundersøgelse med radioaktivt vand" issued by Region Midtjylland worth 6,800,000 DKK.
As of November 1, 2025, Charlotte Vindfeldt has joined the board of directors of MedTrace Pharma A/S.
As of November 1, 2025, Peter Juul Kristensen is registered as adm. dir. of MedTrace Pharma A/S.
As of October 31, 2025, Peter Juul Kristensen has left the board of directors of MedTrace Pharma A/S.
As of June 12, 2025, Lykke Jul Rømer is registered as director of MedTrace Pharma A/S.
As of June 12, 2025, Ann Kristin Brøgger Led has stepped down as adm. dir. of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2024. Revenue came to DKK 2,334,356, and the net result was DKK -15,355,876.
As of May 21, 2025, is registered as an owner of MedTrace Pharma A/S with an ownership share of 5%.
As of May 1, 2025, Lars Trolle has stepped down as director of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2023. Revenue came to DKK 2,645,338, and the net result was DKK -15,106,505.
As of January 1, 2024, Claus Henrik Berner Møller has joined the board of directors of MedTrace Pharma A/S.
As of January 1, 2024, Erik Anders Strömqvist has joined the board of directors of MedTrace Pharma A/S.
As of January 1, 2024, Lars Trolle is registered as director of MedTrace Pharma A/S.
As of January 1, 2024, Ann Kristin Brøgger Led is registered as adm. dir. of MedTrace Pharma A/S.
As of January 1, 2024, Rune Wiik Kristensen has stepped down as director of MedTrace Pharma A/S.
As of January 1, 2024, Erik Anders Strömqvist has stepped down as adm. dir. of MedTrace Pharma A/S.
As of December 31, 2023, Claus Henrik Berner Møller has left the board of directors of MedTrace Pharma A/S.
As of December 31, 2023, Erik Anders Strömqvist has left the board of directors of MedTrace Pharma A/S.
As of December 31, 2023, Ann Kristin Brøgger Led has stepped down as director of MedTrace Pharma A/S.
As of December 4, 2023, Peter Juul Kristensen has joined the board of directors of MedTrace Pharma A/S.
As of September 18, 2023, is registered as an owner of MedTrace Pharma A/S with an ownership share of 10%.
As of September 11, 2023, Mads Spangaard Rasmussen has left the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2022. Revenue came to DKK 2,192,838, and the net result was DKK -37,035,484.
As of December 19, 2022, Martin Dal Stenfeldt has stepped down as adm. dir. of MedTrace Pharma A/S.
As of December 14, 2022, Claus Henrik Berner Møller has joined the board of directors of MedTrace Pharma A/S.
As of December 14, 2022, Erik Anders Strömqvist has joined the board of directors of MedTrace Pharma A/S.
As of December 14, 2022, Erik Anders Strömqvist is registered as adm. dir. of MedTrace Pharma A/S.
As of December 13, 2022, Claus Henrik Berner Møller has left the board of directors of MedTrace Pharma A/S.
As of December 13, 2022, Erik Anders Strömqvist has left the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2021. Revenue came to DKK 1,529,103, and the net result was DKK -17,851,683.
As of April 1, 2022, Ann Kristin Brøgger Led is registered as director of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2020. Gross profit came to DKK 3,011,557, and the net result was DKK 1,244,338.
As of May 11, 2021, Claus Henrik Berner Møller has joined the board of directors of MedTrace Pharma A/S.
As of May 11, 2021, Erik Anders Strömqvist has joined the board of directors of MedTrace Pharma A/S.
As of May 11, 2021, Robert Karl Schier has joined the board of directors of MedTrace Pharma A/S.
As of May 11, 2021, Ulrik Spork has left the board of directors of MedTrace Pharma A/S.
As of May 11, 2021, Michael Frank has left the board of directors of MedTrace Pharma A/S.
As of May 11, 2021, Bernt Skov Jensen has left the board of directors of MedTrace Pharma A/S.
As of May 11, 2021, Rune Wiik Kristensen is registered as director of MedTrace Pharma A/S.
As of May 10, 2021, Erik Anders Strömqvist has left the board of directors of MedTrace Pharma A/S.
As of October 22, 2020, Erik Anders Strömqvist has joined the board of directors of MedTrace Pharma A/S.
As of October 22, 2020, Cesare Orlandi has joined the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2019. Gross profit came to DKK 1,060,541, and the net result was DKK -1,001,671.
MedTrace Pharma A/S has published its annual report for 2018. Gross profit came to DKK -68,239, and the net result was DKK -1,236,840.
On December 28, 2018, the company changed its name from MedTrace A/S to MedTrace Pharma A/S.
As of July 12, 2018, Jens Hesthaven Sørensen has joined the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2017. Gross profit came to DKK -2,166,821, and the net result was DKK -2,002,540.
As of January 29, 2018, Michael Frank has joined the board of directors of MedTrace Pharma A/S.
As of January 29, 2018, Lenna Maria Boe Broberg has left the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2016. Gross profit came to DKK 1,519,441, and the net result was DKK 1,157,243.
As of April 20, 2017, Ulrik Spork has joined the board of directors of MedTrace Pharma A/S.
As of April 20, 2017, Bjarne Henning Jensen has left the board of directors of MedTrace Pharma A/S.
As of August 4, 2016, Lenna Maria Boe Broberg has joined the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2015. Gross profit came to DKK -232,409,000, and the net result was DKK -245,485,000.
On December 17, 2015, the company changed its name from Medtrace ApS to MedTrace A/S.
As of October 5, 2015, KPMG P/S has been appointed auditor of MedTrace Pharma A/S.
As of October 5, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MedTrace Pharma A/S.
As of October 5, 2015, Bjarne Henning Jensen has joined the board of directors of MedTrace Pharma A/S.
As of October 5, 2015, Mads Spangaard Rasmussen has joined the board of directors of MedTrace Pharma A/S.
As of October 5, 2015, Bernt Skov Jensen has joined the board of directors of MedTrace Pharma A/S.
As of October 5, 2015, Peter Larsen has stepped down as director of MedTrace Pharma A/S.
As of October 5, 2015, Rune Wiik Kristensen has stepped down as director of MedTrace Pharma A/S.
On October 5, 2015, the company changed its name from LSW MEDICAL IVS to Medtrace ApS.
As of January 5, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MedTrace Pharma A/S.
As of January 5, 2015, Martin Dal Stenfeldt is registered as adm. dir. of MedTrace Pharma A/S.
As of January 5, 2015, Peter Larsen is registered as director of MedTrace Pharma A/S.
As of January 5, 2015, Rune Wiik Kristensen is registered as director of MedTrace Pharma A/S.
MedTrace Pharma A/S was founded on January 5, 2015.
Companies in the same industry and area
CVR 36053941
CVR 29773157
CVR 21482242
CVR 19717690
CVR 44624842
